Curatis Holding AG is a specialty pharmaceutical company based in Switzerland, which engages in acquisition, development and commercialization of innovative medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. The company was founded by Günter Graubach, and is headquartered in Liestal, Switzerland.